Human serum-induced porcine endothelial cell E-selectin expression is associated with IgG3 and IgM anti-Gal antibodies

Xenotransplantation

Volumn 9, Issue 5, 2002, Pages 350-358

  Sæthre, Marit ^a   Sølvik, Una Ø ^a   Haraldsen, Guttorm ^a   Fiane, Arnt E ^a   Boretti, Eva ^a   Thorsby, Erik ^a   Platt, Jeffrey L ^b   Mollnes, Tom E ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b MAYO CLINIC   (United States)

Author keywords

Anti Gal antibodies; Complement; E selectin; Endothelial cell activation; Human serum; IgG subclasses; Xenotransplantation

Indexed keywords

ANTIBODY; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GALACTOSYL ANTIBODY; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANTIBODY TITER; ARTICLE; CELL ACTIVATION; ENDOTHELIUM CELL; FEMALE; HUMAN; HYPERACUTE GRAFT REJECTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SWINE;

ADULT; AGE FACTORS; ANIMALS; ANTIBODIES, HETEROPHILE; ANTIBODY SPECIFICITY; DISACCHARIDES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; E-SELECTIN; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; FUCOSE; GALACTOSE; GRAFT REJECTION; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; SEX FACTORS; SWINE; VARIATION (GENETICS);

EID: 0036766238     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3089.2002.01094.x     Document Type: Article

References (44)

1. GOOD AH, COOPER DK, MALCOLM AJ et al. Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. Transplant Proc 1992; 24: 559.
2. ORJOL R, YE Y, KOREN E, COOPER DKC. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplantation 1993; 56: 1433.
3. SANDRIN MS, VAUGHAN HA, DABKOWSKI PL, MCKENZIE IF. Anti-pig IgM antibodies in human serum react predominantly with Gal (alpha 1-3) Gal epitopes. Proc Natl Acad Sci USA 1993; 90: 11391.
4. PLATT JL, FISCHEL RJ, MATAS AJ et al. Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation 1991; 52: 214.
5. PARKER W, BRUNO D, HOLZKNECHT ZE, PLATT JL. Characterization and affinity isolation of xcnoreactive human natural antibodies. J Immunol 1994; 153: 3791.
6. MCMORROW IM, COMRACK CA, SACHS DH, DERSIMONIAN H. Heterogeneity of human anti-pig natural antibodies cross-reactive with the Gal (alpha 1, 3) galactose epitope. Transplantation 1997; 64: 501.
7. BARREAU N, BLANCHO G, BOULET C et al. Natural anti-Gal antibodies constitute 0.2% of intravenous immunoglobulin and are equally retained on a synthetic disaccharide column or on an immobilized natural glycoprotein. Transplant Proc 2000; 32: 882.
8. CHIANG TR, FANGET L, GREGORY R et al. Anti-Gal antibodies in humans and 1, 3 alpha-galactosyl transferase knock-out mice. Transplantation 2000; 69: 2593.
9. GALILI U, RACHMILEWITZ EA, PELEG A, FLECHNER I. A unique natural human IgG antibody with anti-alpha-galactosyl specificity. J Exp Med 1984; 160: 1519.
10. GALILI U, ANARAKI F, THALL A et al. One percent of human circulating B lymphocytes are capable of producing the natural anti-Gal antibody. Blood 1993; 82: 2485.
11. NEETHLING FA, KOREN E, YE Y et al. Protection of pig kidney (PK15) cells from the cytotoxic effect of anti-pig antibodies by alpha-galactosyl oligosaccharides. Transplantation 1994; 57: 959.
12. KAPLON RJ, MICHLER RE, Xu H et al. Absence of hyperacute rejection in newborn pig-to-baboon cardiac xenografts. Transplantation 1995; 59: 1.
13. XU Y, LORF T, SABLINSKI T et al. Removal of anti-porcine natural antibodies from human and nonhuman primate plasma in vitro and in vivo by a Gal alpha 1-3Gal beta 1-4 beta Glc-X immunoaffinity column. Transplantation 1998; 65: 172.
14. MCCURRY KR, KOOYMAN DL, ALVARADO CG et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nature Med 1995; 1: 423.
15. COZZI E, WHITE DJG. The generation of transgenic pigs as potential organ donors for humans, Nature Med 1995; 1: 964.
16. PLATT JL, LIN SS, MCGREGOR CGA. Acute vascular rejection. Xenotransplantation 1998; 5: 169.
17. BACH FH, WINKLER H, FERRAN C et al. Delayed xenograft rejection. Immunol Today 1996; 17: 379.
18. BRACY JL, CRETIN N, COOPER DKC, IACOMINI J. Xenore-active natural antibodies. Cell Mol Life Sci 1999; 56: 1001.
19. LIN SS, HANAWAY MJ, GONZALEZ-STAWINSKi GV et al. The role of anti-Gal alpha 1-3Gal antibodies in acute vascular rejection and accommodation of xenografts. Transplantation 2000; 70: 1667.
20. LOSS M, VANGEROW B, SCHMIDTKO J et al. Acute vascular rejection is associated with systemic complement activation in a pig-to-primate kidney xenograft model. Xenotransplantation 2000; 7: 186.
21. DAVIS EA, PRUITT SK, GREENE PS et al. Inhibition of complement, evoked antibody, and cellular response prevents rejection of pig-to-primate cardiac xenografts. Transplantation: 1996; 62: 1018.
22. ZAIDI A, SCHMOECKEL M, BHATTI F et al. Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors. Transplantation 1998; 65: 1584.
23. SELVAN RS, KAPADIA HB, PLATT JL. Complement-induced expression of chemokine genes in endothelium: regulation by IL-1-dependent and -independent mechanisms. J Immunol 1998; 161: 4388.
24. SAADI S, HOLZKNECHT RA, PATTE CP, PLATT JL. Endothelial cell activation by pore-forming structures - Pivotal role for interleukin-1 alpha. Circulation 2000; 101: 1867.
25. SØLVIK UO, HARALDSEN G, FIANE AE et al. Human serum-induced expression of E-selectin on porcine aortic endothelial cells in vitro is totally complement mediated. Transplantation 2001; 72: 1967.
26. Yu PB, PARKER W, EVERETT ML et al. Immunochemical properties of anti-Gal alpha 1-3Gal antibodies after sensitization with xenogeneic tissues. J Clin Immunol 1999; 19: 116.
27. RIEBEN R, BOVIN NV, KORCHAGINA EY et al. Xenotransplantation: in vitro analysis of synthetic alpha-galactosyl inhibitors of human anti-Gal alpha 1-3Gal IgM and IgG antibodies. Glycobiology 2000; 10: 141.
28. MANEZ R, BLANCO FJ, DIAZ I et al. Removal of bowel aerobic gram-negative bacteria is more effective than immunosuppression with cyclophosphamide and steroids to decrease natural alpha-galactosyl IgG antibodies. Xenotransplantation 2001; 8: 15.
29. BUONOMANO R, TINGUELY C, RIEBEN R et al. Quantitation and characterization of anti-Gal alpha 1-3Gal antibodies in sera of 200 healthy persons. Xenotransplantation 1999; 6: 173.
30. WANG L, ANARAKI F, HENION TR, GALILI U. Variations in activity of the human natural anti-Gal antibody in young and elderly populations. J Gerontol a Biol Sci Med Sci 1995; 50: M227-M233.
31. GALILI U. Abnormal expression of alpha-galactosyl epitopes in man. A trigger for autoimmune processes? Lancet 1989; 2: 358.
32. GALILI U. Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibody. Springer Semin Immunopathol 1993; 15: 155.
33. WINAND RJ, DEVIGNE JW, MEURISSE M, GALILI U. Specific stimulation of Graves' disease thyrocytes by the natural anti-Gal antibody from normal and autologous serum. J Immunol 1994; 153: 1386.
34. ICHIKAWA Y, YAMADA C, HORIKI T et al. Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjogren's syndrome and rheumatoid arthritis. Clin Exp Rheumatol 1998; 16: 709.
35. PARKER W, LIN SS, Yu PB et al. Naturally occurring anti-alpha-galactosyl antibodies: relationship to xenoreactive anti-alpha-galactosyl antibodies. Glycobiology 1999; 9: 865.
36. PLATT JL, LINDMAN BJ, GELLER RL et al. The role of natural antibodies in the activation of xenogenic endothelial cells. Transplantation 1991; 52: 1037.
37. GAMBIEZ L, SALAME E, CHEREAU C et al. The role of natural IgM in the hyperacute rejection of discordant heart xenografts. Transplantation 1992; 54: 577.
38. KROSHUS TJ, BOLMAN RM, DALMASSO AP. Selective IgM depletion prolongs organ survival in an ex vivo model of pig-to-human xenotransplantation. Transplantation 1996; 62: 5.
39. KOREN E, KUJUNDZIC M, KOSCEC M et al. Cytotoxic effects of human preformed anti-GAL IgG and complement on cultured pig cells. Transplant Proc 1994; 26: 1336.
40. YU PB, HOLZKNECHT ZE, BRUNO D et al. Modulation of natural IgM binding and complement activation by natural IgG antibodies - a role for IgG anti-Gal alpha 1-3Gal antibodies. J Immunol 1996; 157: 5163.
41. MCKANE W, LEE J, PRESTON R et al. IgG (2) anti-GAL alpha 1-3GAL does not induce porcine aortic endothelial cell accommodation in vitro. Transplantation 2000; 70: 1085.
42. ROOS A, ESSERS M, GIJLSWIJK-JANSSEN D et al. Both IgG and IgM anti-pig antibodies induce complement activation and cytotoxicity. Xenotransplantation 2001; 8: 3.
43. PALMETSHOFER, A, GALILI U, DALMASSO AP et al. Alpha- galactosyl epitope-mediated activation of porcine aortic endothelial cells - type II activation. Transplantation 1998; 65: 971.
44. MCKANE W, LEE J, PRESTON R et al. Polymorphism in the human anti-pig natural antibody repertoire - implications for antigen-specific immunoadsorption. Transplantation 1998; 66: 626.